home All News open_in_new Full Article

Mirxes wins China’s approval to launch groundbreaking gastric cancer blood test

Cancer screening device developer Mirxes Holding has won approval from Beijing to launch a gastric cancer test, the first blood test for the disease in China’s vast oncology diagnostics market. Its leading product, GastroClear, an in-house-developed non-invasive blood test, was approved by the National Medical Products Administration of China, the Singapore-based micro ribonucleic acid (miRNA) technology firm said in a filing to Hong Kong’s stock exchange on Thursday. “GastroClear is the world’s...


today 1 week ago attach_file Events

attach_file Politics
attach_file Society
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 2906773391
Add Watch Country

arrow_drop_down